TCRX
Tscan Therapeutics Inc
0.2754$
+0.0%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -396.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.5% | -2.0% | -11.0% | -8.0% | -30.8% | -4.6% | +2.9% | +9.9% | -5.7% | -4.1% | +0.9% | – | |
| – | +11.9% | +32.3% | +17.3% | +8.4% | +7.6% | +25.8% | -4.1% | -8.0% | -33.3% | +22.8% | -4.4% | – | |
| – | -121.8% | – | – | -112.8% | – | -221.4% | – | -193.0% | – | – | -141.1% | – | |
| – | -66.9% | +50.3% | +22.3% | +58.9% | -35.2% | +72.5% | -16.5% | +11.4% | -88.0% | -59.1% | +604.3% | – | |
| – | – | +1,790.4% | -193.2% | +144.3% | – | -50.4% | +258.0% | -32.7% | -54.5% | -100.5% | +564.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +1,257.9% | +62,530.6% | -99.2% | +3,614.6% | -101.1% | – | -100.0% | – | -100.0% | – | – | |
| – | – | – | +1,320.8% | -207.3% | – | -153.9% | – | -99.3% | -15,367.9% | – | – | – | |
| – | -467.3% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.